Doxorubicin Global Strategic Research Report 2024: Market to Reach $1.7 Billion by 2030 from $1.1 Billion in 2023, Driven by Rise in Cancer Incidence and Innovations in Cancer Drug Delivery
05 avr. 2024 09h07 HE
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Doxorubicin - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Doxorubicin Market to Reach $1.7...
Aflibercept (Eylea) Biosimilars Pipeline Review 2024: Patents are Due to Run out from 2023 to 2032
23 févr. 2024 07h32 HE
|
Research and Markets
Dublin, Feb. 23, 2024 (GLOBE NEWSWIRE) -- The "Aflibercept (Eylea) Biosimilars Pipeline Review" report has been added to ResearchAndMarkets.com's offering.This product provides basic information on...
Global Thyroid Cancer Drugs Market Report 2024: Highlights Trends in Targeted Therapies, Featuring Profiles of Mylan Pharmaceuticals, AstraZeneca, Exelixis, Pfizer, and Bristol-Myers Squibb
23 janv. 2024 15h28 HE
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Thyroid Cancer Drugs Global Market 2024" report has been added to ResearchAndMarkets.com's offering. The global thyroid cancer drugs market...
Pemetrexed + Cisplatin Drug Insights and Market Forecasts 2019-2032: The Standard of Care Front Line Regimen for Malignant Pleural Mesothelioma
12 déc. 2023 04h58 HE
|
Research and Markets
Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "Pemetrexed + cisplatin Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
Global Thyroid Cancer Drugs Market to Reach $1.29 Billion by 2027: Targeted Therapies Transforming Thyroid Cancer Treatment
31 juil. 2023 05h33 HE
|
Research and Markets
Dublin, July 31, 2023 (GLOBE NEWSWIRE) -- The "Thyroid Cancer Drugs Global Market Report 2023" has been added to ResearchAndMarkets.com's offering. This report provides a comprehensive guide to...
Global Thyroid Cancer Drugs Market Report 2023: Increasing Focus on Early Diagnosis and Treatment Drives Growth
09 mai 2023 07h49 HE
|
Research and Markets
Dublin, May 09, 2023 (GLOBE NEWSWIRE) -- The "Global Thyroid Cancer Drugs Market by Drug (Cabozantinib-S-Malate, Caprelsa, Cometriq), End User (Hospitals, Oncology Clinics, Research Organizations) -...
Thyroid Cancer Market to Grow at a Substantial Growth Rate, Predicts DelveInsight | Novartis, AffyImmune Therapeutics, Eli Lilly, Loxo Oncology, Bristol-Myers Squibb, and Others Expected to Propel Market
12 avr. 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, April 12, 2023 (GLOBE NEWSWIRE) -- Thyroid Cancer Market to Grow at a Substantial Growth Rate, Predicts DelveInsight | Novartis, AffyImmune Therapeutics, Eli Lilly, Loxo Oncology,...
Lenvatinib + pembrolizumab Emerging Drug Insight and Market Forecast 2022 - 2032
06 avr. 2023 05h03 HE
|
Research and Markets
Dublin, April 06, 2023 (GLOBE NEWSWIRE) -- The "Lenvatinib + pembrolizumab Emerging Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering.This...
Outlook on the Liposomal Doxorubicin Global Market: Industry Analysis for 2015-2021 and Opportunity Assessment for 2022-2032
04 nov. 2022 07h28 HE
|
Research and Markets
Dublin, Nov. 04, 2022 (GLOBE NEWSWIRE) -- The "Liposomal Doxorubicin Market" report has been added to ResearchAndMarkets.com's offering.A recent market study published on Liposomal Doxorubicin...
China Aflibercept Market Investigation Report 2022: Regeneron has Exclusive Sales Rights in the U.S. Market, while Bayer Obtains Exclusive Sales Rights Outside the U.S
10 août 2022 05h18 HE
|
Research and Markets
Dublin, Aug. 10, 2022 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Aflibercept Market 2022-2031" report has been added to ResearchAndMarkets.com's offering. Aflibercept is an anti-VEGF...